Clinical trial
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment…
NCT00095017 · Organon and Co, Industry · Withdrawn
Key facts
| NCT number | NCT00095017 |
|---|---|
| Title | Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083) |
| Official title | A 4 Week Randomized, Placebo-Controlled, Parallel Group, Double-Blind Pilot Study to Assess the Safety and Efficacy of Etoricoxib 90 mg Versus Placebo in the Treatment of Cancer Pain |
| Lead sponsor | Organon and Co, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bone Neoplasms |
| Intervention type | Drug |
| Interventions | MK0663, etoricoxib / Duration of Treatment: 4 weeks |
| Enrollment | 0 |
| Start date | Nov 1, 2004 |
| First posted | Nov 1, 2004 |
| Last update posted | Feb 16, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: